文献速递传染病防控与疫情报告卫生政策与健康促进

更新:第五次流行期间中国新型亚洲谱系禽流感A(H7N9)病毒感染人间病例增加,2016年10月1日至2017年8月7日

Update: Increase in Human Infections with Novel Asian Lineage Avian Influenza A(H7N9) Viruses During the Fifth Epidemic - China, October 1, 2016-August 7, 2017.
PubMed 文献 · MMWR Morb Mortal Wkly Rep · 2017-09-08

2016年10月1日至2017年8月7日,中国国家卫生和计划生育委员会、台湾CDC、香港卫生防护中心和澳门CDC向WHO报告了759例人感染亚洲H7N9病毒病例,其中281例死亡,为2013年以来五次流行中规模最大的一次。本报告总结了第五次流行期间发现的病毒和流行病学新特征及大流行防范措施。

要点

  • 第五次流行报告759例人感染亚洲H7N9病毒,其中281例死亡,为2013年以来最大流行。
  • 大多数人感染与活禽市场暴露相关,普通公众风险很低。
  • 第五次流行检测到高致病性禽流感病毒及对推荐抗病毒药物敏感性降低的病毒。

核心结论

  • 第五次亚洲H7N9流行规模为2013年以来最大,报告759例人感染和281例死亡。
  • 病毒出现高致病性变异和对推荐抗病毒药物敏感性降低,并遗传 diverged 为两个谱系。
  • 普通公众风险很低,多数人感染与活禽市场暴露相关。

研究设计与样本

  • 基于CDC的流感风险评估工具(IRAT),亚洲谱系H7N9病毒被评为大流行风险最高的流感病毒。
  • 中国国家卫生和计划生育委员会、台湾CDC、香港卫生防护中心和澳门CDC向WHO报告病例。
  • 报告总结第五次流行(2016年10月1日至2017年8月7日)的新病毒和流行病学特征及大流行防范措施。

主要发现

  • 2016年10月1日至2017年8月7日报告759例人感染亚洲H7N9病毒,其中281例死亡。
  • 人间和禽间感染报告来自中国大部分地区,包括与他国接壤的省份,表明地理传播广泛持续。
  • 前四次流行仅检测到低致病性禽流感病毒,第五次流行检测到高致病性禽流感病毒及对推荐抗病毒药物敏感性降低的病毒。
  • 第五次流行病毒遗传 diverged 为珠江三角洲谱系和长江三角洲谱系,长江三角洲谱系病毒抗原性与早期流行病毒不同。

临床怎么用

  • CDC正与合作伙伴加强人间和禽间亚洲H7N9病毒监测。
  • CDC正提高实验室检测和表征H7N9病毒的能力。
  • CDC正开发、测试和分发新的候选疫苗病毒(CVV),以备疫苗生产需要。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Among all influenza viruses assessed using CDC's Influenza Risk Assessment Tool (IRAT), the Asian lineage avian influenza A(H7N9) virus (Asian H7N9), first reported in China in March 2013,* is ranked as the influenza virus with the highest potential pandemic risk (1). During October 1, 2016-August 7, 2017, the National Health and Family Planning Commission of China; CDC, Taiwan; the Hong Kong Centre for Health Protection; and the Macao CDC reported 759 human infections with Asian H7N9 viruses, including 281 deaths, to the World Health Organization (WHO), making this the largest of the five epidemics of Asian H7N9 infections that have occurred since 2013 (Figure 1). This report summarizes new viral and epidemiologic features identified during the fifth epidemic of Asian H7N9 in China and summarizes ongoing measures to enhance pandemic preparedness. Infections in humans and poultry were reported from most areas of China, including provinces bordering other countries, indicating extensive, ongoing geographic spread. The risk to the general public is very low and most human infections were, and continue to be, associated with poultry exposure, especially at live bird markets in mainland China. Throughout the first four epidemics of Asian H7N9 infections, only low pathogenic avian influenza (LPAI) viruses were detected among human, poultry, and environmental specimens and samples. During the fifth epidemic, mutations were detected among some Asian H7N9 viruses, identifying the emergence of high pathogenic avian influenza (HPAI) viruses as well as viruses with reduced susceptibility to influenza antiviral medications recommended for treatment. Furthermore, the fifth-epidemic viruses diverged genetically into two separate lineages (Pearl River Delta lineage and Yangtze River Delta lineage), with Yangtze River Delta lineage viruses emerging as antigenically different compared with those from earlier epidemics. Because of its pandemic potential, candidate vaccine viruses (CVV) were produced in 2013 that have been used to make vaccines against Asian H7N9 viruses circulating at that time. CDC is working with partners to enhance surveillance for Asian H7N9 viruses in humans and poultry, to improve laboratory capability to detect and characterize H7N9 viruses, and to develop, test and distribute new CVV that could be used for vaccine production if a vaccine is needed.

来源:MMWR Morb Mortal Wkly Rep,查看原文。版权归原作者所有。

引用

  1. Kile JC, Ren R, Liu L, et al. Update: Increase in Human Infections with Novel Asian Lineage Avian Influenza A(H7N9) Viruses During the Fifth Epidemic - China, October 1, 2016-August 7, 2017. MMWR Morb Mortal Wkly Rep. 2017. PMID: 28880856. doi:10.15585/mmwr.mm6635a2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。